Santiago Clocchiatti-Tuozzo, Cyprien A Rivier, Shubham Misra, Johan Zelano, Rajarshi Mazumder, Lauren H Sansing, Adam de Havenon, Lawrence J Hirsch, David S Liebeskind, Emily J Gilmore, Kevin N Sheth, Jennifer A Kim, Bradford B Worrall, Guido J Falcone, Nishant K Mishra
{"title":"癫痫和中风后癫痫的多基因风险。","authors":"Santiago Clocchiatti-Tuozzo, Cyprien A Rivier, Shubham Misra, Johan Zelano, Rajarshi Mazumder, Lauren H Sansing, Adam de Havenon, Lawrence J Hirsch, David S Liebeskind, Emily J Gilmore, Kevin N Sheth, Jennifer A Kim, Bradford B Worrall, Guido J Falcone, Nishant K Mishra","doi":"10.1161/STROKEAHA.124.047459","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Epilepsy is highly heritable, with numerous known genetic risk loci. However, the genetic predisposition's role in poststroke epilepsy (PSE) remains understudied. This study assesses whether a higher genetic predisposition to epilepsy raises poststroke survivor's risk of PSE.</p><p><strong>Methods: </strong>We conducted a case-control genetic association study nested within the UK Biobank, a large UK-based prospective cohort. Our exposures of interest were 2 distinct polygenic risk scores-generalized and focal epilepsy-modeled as deciles and constructed using genetic variants identified in the latest International League Against Epilepsy genome-wide association study meta-analysis. We aimed to evaluate the association between these polygenic risk scores and their corresponding subtype of PSE-generalized and focal. In sensitivity analyses, we evaluated participants of European ancestry separately and considered focal and generalized epilepsy outcomes in participants without a history of stroke. In secondary analyses, we evaluated the polygenic risk of PSE by stroke subtype (ischemic, hemorrhagic, or any stroke). Multivariable logistic regression models were fitted, adjusting for age, sex, genetic ancestry, and the first 5 principal genetic components.</p><p><strong>Results: </strong>Among 17 549 UK Biobank stroke survivors with available genetic information (mean age, 61; 43% female), 185 (1%) developed generalized PSE, while 124 (0.7%) developed focal PSE. Multivariable logistic regression results showed that, when compared against the lowest decile, participants within the highest PRS decile for generalized PSE had 5-fold higher odds of developing generalized PSE (OR, 5.05 [95% CI, 2.37-12.5]; <i>P</i> trend<0.001). Similarly, when compared against the lowest decile, participants within the highest polygenic risk score decile for focal PSE had 3-fold higher odds of developing focal PSE (OR, 3.20; [5% CI, 1.25-9.82]; <i>P</i> trend=0.024). Sensitivity analyses among participants of European ancestry yielded similar results.</p><p><strong>Conclusions: </strong>Our findings suggest that, like other forms of epilepsy, genetic predisposition plays an essential role in PSE. These results underscore the need for future studies to elucidate the mechanisms underlying PSE development and to identify novel therapeutic avenues.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Polygenic Risk of Epilepsy and Poststroke Epilepsy.\",\"authors\":\"Santiago Clocchiatti-Tuozzo, Cyprien A Rivier, Shubham Misra, Johan Zelano, Rajarshi Mazumder, Lauren H Sansing, Adam de Havenon, Lawrence J Hirsch, David S Liebeskind, Emily J Gilmore, Kevin N Sheth, Jennifer A Kim, Bradford B Worrall, Guido J Falcone, Nishant K Mishra\",\"doi\":\"10.1161/STROKEAHA.124.047459\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Epilepsy is highly heritable, with numerous known genetic risk loci. However, the genetic predisposition's role in poststroke epilepsy (PSE) remains understudied. This study assesses whether a higher genetic predisposition to epilepsy raises poststroke survivor's risk of PSE.</p><p><strong>Methods: </strong>We conducted a case-control genetic association study nested within the UK Biobank, a large UK-based prospective cohort. Our exposures of interest were 2 distinct polygenic risk scores-generalized and focal epilepsy-modeled as deciles and constructed using genetic variants identified in the latest International League Against Epilepsy genome-wide association study meta-analysis. We aimed to evaluate the association between these polygenic risk scores and their corresponding subtype of PSE-generalized and focal. In sensitivity analyses, we evaluated participants of European ancestry separately and considered focal and generalized epilepsy outcomes in participants without a history of stroke. In secondary analyses, we evaluated the polygenic risk of PSE by stroke subtype (ischemic, hemorrhagic, or any stroke). Multivariable logistic regression models were fitted, adjusting for age, sex, genetic ancestry, and the first 5 principal genetic components.</p><p><strong>Results: </strong>Among 17 549 UK Biobank stroke survivors with available genetic information (mean age, 61; 43% female), 185 (1%) developed generalized PSE, while 124 (0.7%) developed focal PSE. Multivariable logistic regression results showed that, when compared against the lowest decile, participants within the highest PRS decile for generalized PSE had 5-fold higher odds of developing generalized PSE (OR, 5.05 [95% CI, 2.37-12.5]; <i>P</i> trend<0.001). Similarly, when compared against the lowest decile, participants within the highest polygenic risk score decile for focal PSE had 3-fold higher odds of developing focal PSE (OR, 3.20; [5% CI, 1.25-9.82]; <i>P</i> trend=0.024). Sensitivity analyses among participants of European ancestry yielded similar results.</p><p><strong>Conclusions: </strong>Our findings suggest that, like other forms of epilepsy, genetic predisposition plays an essential role in PSE. These results underscore the need for future studies to elucidate the mechanisms underlying PSE development and to identify novel therapeutic avenues.</p>\",\"PeriodicalId\":21989,\"journal\":{\"name\":\"Stroke\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.8000,\"publicationDate\":\"2024-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stroke\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/STROKEAHA.124.047459\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/STROKEAHA.124.047459","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:癫痫具有高度遗传性,有许多已知的遗传风险位点。然而,遗传易感性在脑卒中后癫痫(PSE)中的作用仍未得到充分研究。本研究评估了较高的癫痫遗传易感性是否会提高脑卒中后幸存者患 PSE 的风险:我们在英国生物库(UK Biobank)中进行了一项病例对照遗传关联研究,英国生物库是英国的一个大型前瞻性队列。我们所关注的风险暴露是两个不同的多基因风险评分--全身性癫痫和局灶性癫痫--以十分位数为模型,并利用国际抗癫痫联盟最新的全基因组关联研究荟萃分析中确定的基因变异构建而成。我们的目的是评估这些多基因风险评分与相应的 PSE 亚型(全身性和局灶性)之间的关联。在敏感性分析中,我们分别评估了欧洲血统的参与者,并考虑了无中风史参与者的局灶性和全身性癫痫结果。在二次分析中,我们按中风亚型(缺血性、出血性或任何中风)评估了 PSE 的多基因风险。我们拟合了多变量逻辑回归模型,并对年龄、性别、遗传血统和前 5 个主要遗传成分进行了调整:结果:在 17 549 名有遗传信息的英国生物库中风幸存者(平均年龄 61 岁,43% 为女性)中,185 人(1%)出现全身性 PSE,124 人(0.7%)出现局灶性 PSE。多变量逻辑回归结果显示,与最低十分位数相比,PRS最高十分位数的参与者发生全身性PSE的几率高出5倍(OR,5.05 [95% CI,2.37-12.5];P trend=0.024)。对欧洲血统参与者的敏感性分析也得出了类似的结果:我们的研究结果表明,与其他形式的癫痫一样,遗传易感性在 PSE 中起着至关重要的作用。这些结果表明,未来的研究需要阐明 PSE 的发病机制,并找出新的治疗途径。
Polygenic Risk of Epilepsy and Poststroke Epilepsy.
Background: Epilepsy is highly heritable, with numerous known genetic risk loci. However, the genetic predisposition's role in poststroke epilepsy (PSE) remains understudied. This study assesses whether a higher genetic predisposition to epilepsy raises poststroke survivor's risk of PSE.
Methods: We conducted a case-control genetic association study nested within the UK Biobank, a large UK-based prospective cohort. Our exposures of interest were 2 distinct polygenic risk scores-generalized and focal epilepsy-modeled as deciles and constructed using genetic variants identified in the latest International League Against Epilepsy genome-wide association study meta-analysis. We aimed to evaluate the association between these polygenic risk scores and their corresponding subtype of PSE-generalized and focal. In sensitivity analyses, we evaluated participants of European ancestry separately and considered focal and generalized epilepsy outcomes in participants without a history of stroke. In secondary analyses, we evaluated the polygenic risk of PSE by stroke subtype (ischemic, hemorrhagic, or any stroke). Multivariable logistic regression models were fitted, adjusting for age, sex, genetic ancestry, and the first 5 principal genetic components.
Results: Among 17 549 UK Biobank stroke survivors with available genetic information (mean age, 61; 43% female), 185 (1%) developed generalized PSE, while 124 (0.7%) developed focal PSE. Multivariable logistic regression results showed that, when compared against the lowest decile, participants within the highest PRS decile for generalized PSE had 5-fold higher odds of developing generalized PSE (OR, 5.05 [95% CI, 2.37-12.5]; P trend<0.001). Similarly, when compared against the lowest decile, participants within the highest polygenic risk score decile for focal PSE had 3-fold higher odds of developing focal PSE (OR, 3.20; [5% CI, 1.25-9.82]; P trend=0.024). Sensitivity analyses among participants of European ancestry yielded similar results.
Conclusions: Our findings suggest that, like other forms of epilepsy, genetic predisposition plays an essential role in PSE. These results underscore the need for future studies to elucidate the mechanisms underlying PSE development and to identify novel therapeutic avenues.
期刊介绍:
Stroke is a monthly publication that collates reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases. The publication covers a wide range of disciplines including anesthesiology, critical care medicine, epidemiology, internal medicine, neurology, neuro-ophthalmology, neuropathology, neuropsychology, neurosurgery, nuclear medicine, nursing, radiology, rehabilitation, speech pathology, vascular physiology, and vascular surgery.
The audience of Stroke includes neurologists, basic scientists, cardiologists, vascular surgeons, internists, interventionalists, neurosurgeons, nurses, and physiatrists.
Stroke is indexed in Biological Abstracts, BIOSIS, CAB Abstracts, Chemical Abstracts, CINAHL, Current Contents, Embase, MEDLINE, and Science Citation Index Expanded.